Aridis Pharmaceuticals's market cap is currently $4.46K. The company's EPS TTM is $-0.156; its P/E ratio is ―; Aridis Pharmaceuticals is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 1.00M	$ 1.02M	$ 2.76M
Gross Profit	$ 0.00	$ 0.00	$ 1.00M	$ 1.02M	$ 2.76M
Operating Income	$ -29.99M	$ -43.71M	$ -22.40M	$ -29.09M	$ -24.12M
EBITDA	$ -29.51M	$ -44.43M	$ -22.06M	$ -28.75M	$ -23.83M
Net Income	$ -30.75M	$ -42.28M	$ -21.92M	$ -28.99M	$ -22.11M
Balance Sheet
Cash & Short-Term Investments	$ 4.88M	$ 19.99M	$ 8.23M	$ 20.90M	$ 24.24M
Total Assets	$ 14.70M	$ 26.80M	$ 15.12M	$ 27.97M	$ 31.61M
Total Debt	$ 6.13M	$ 5.98M	$ 715.00K	$ 0.00	$ 0.00
Net Debt	$ 1.25M	$ -14.01M	$ -7.52M	$ -20.90M	$ -24.24M
Total Liabilities	$ 38.93M	$ 40.91M	$ 23.80M	$ 24.33M	$ 5.30M
Stockholders' Equity	$ -24.23M	$ -14.11M	$ -8.68M	$ 3.64M	$ 26.31M
Cash Flow
Free Cash Flow	$ -29.21M	$ -23.47M	$ -20.84M	$ -8.33M	$ -24.95M
Operating Cash Flow	$ -29.13M	$ -22.94M	$ -20.48M	$ -8.16M	$ -24.27M
Investing Cash Flow	$ -82.00K	$ -530.00K	$ -367.00K	$ -174.00K	$ -1.68M
Financing Cash Flow	$ 14.78M	$ 34.72M	$ 8.68M	$ 4.99M	$ 25.09M

Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History

Income Statement >

Aridis Pharmaceuticals Debt to Assets

Balance Sheet >

Aridis Pharmaceuticals Cash Flow

Cash Flow >

Aridis Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing